- Home
- Companies
- SCHOTT Pharma
- Products
- syriQ BioPure® - Syringe Solutions for ...
syriQ BioPure® - Syringe Solutions for Biologics
Complex biotech drugs face a variety of challenges when it comes to primary packaging. Any interaction between the drug and the prefilled syringe for biologics can impact stability and treatment efficiency. Ions may leach out of the glass, silicone may interact with the drug, and tungsten residues may cause protein degradation or aggregation.
syriQ BioPure® prefillable glass syringes (PFS) are manufactured using specially developed technology to ensure ultra-low residuals levels, minimizing the risk of drug-container interactions over the full product shelf life. Designed for optimum functionality and seamless device integration with autoinjectors and safety systems, syriQ BioPure® syringes for biologics offer safe and easy drug administration for the patient.
syriQ BioPure® glass syringes for biologics are made of high-quality FIOLAX® Borosilicate Glass and offer superior functionality, safe and easy drug administration, and high levels of patient comfort.
- Low levels of particles and ultra-low tungsten and glue residuals.
- Consistent gliding and injection force.
- Tight dimensional specifications and geometrical tolerances.
- Proven compatibility with safety devices and autoinjectors.
- 360° support from a single source, including technical consulting, quality and compliance statements, and analytical services.
- Made using high quality Type I FIOLAX® Borosilicate Glass.
- Format options include 2.25 ml staked needle and 1ml lg staked needle, with more than 50 verified syringe configurations available.
- Packaged in nest 100 (1 ml lg + 2.25 ml) or nest 160 (1 ml lg).
